ALS Limited Falls Despite Record FY26 Profit
ALS Limited (ASX: ALQ) shares slipped 1.7% on Monday to close at A$21.83, even after the lab testing giant reported the strongest year in its history. Revenue climbed 10.7% to A$3.32 billion and underlying profit jumped 25.8% to A$381.2 million, with the company also paying down debt. So…
Pro Medicus Wins A$90m Beth Israel Lahey Deal
Pro Medicus (ASX:PME) has landed another major US contract, signing a seven-year, A$90m deal with Beth Israel Lahey Health, a Boston-based hospital network. The contract will see Pro Medicus roll out its cloud-based Visage 7 imaging platform across 14 hospitals in Massachusetts and New Hampshire, with the…
KTEK Aerosystems (ASX:KTK) has listed with UAV defence exposure, revenue growth and clear balance sheet risks investors need to watch.
AI chip hype, OpenAI backlog risk and IPO supply pressure collide
When Cerebras systems went public last week, we noted that it was one of the largest tech IPOs in recent memory. The stock priced at US$185 per share before opening at US$350, which tells you how intense the demand was from day one.
This was…
Tuas Limited (ASX:TUA) faces a suspended IMDA review of its M1 acquisition after a Simba spectrum allegation, with the 21 May long-stop now looming.
Reach Resources (ASX:RR1) has signed a binding option agreement with Andel Resources to fully fund its Murchison South Gold Project through to production.
Bass Oil (ASX:BAS) posted A$1.35m April revenue as Cooper Basin stockpiles cleared and Bunian 6 lined up to double group oil production.
Elders Limited (ASX:ELD) delivered HY26 EBIT of A$76.6m, up 33%, but leverage at 3.8x and a mid-transition balance sheet shape the H2 outlook.
Life360 (ASX:360) has authorised a US$225m multi-year buyback aimed squarely at offsetting stock-based compensation dilution.
Brambles (ASX:BXB) cuts FY26 profit guidance on a US$60m US repair capacity hit, but announces a new US$400m on-market buyback.
